Video

ARVO 2020: OCT-A vs laser speckle contrast imaging

Author(s):

Alex Delaney-Gesing ,David Hutton
Conferences|ARVO


Osamah Saeedi, MD, MS, speaks with Ophthalmology Times® David Hutton on the highlights of his presentation "OCT angiography vs laser speckle contrast imaging," where he analyzes the correlation of static and dynamic measurements of peripapillary blood flow in glaucoma, glaucoma suspect, and healthy eyes, during the 2020 virtual ARVO meeting.

See more ARVO meeting coverage here

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
Related Content
Potential biomarkers of primary open-angle glaucoma in patient serum in Nigeria
April 23rd 2025

Potential biomarkers of primary open-angle glaucoma in patient serum in Nigeria

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Companies announce presentations at upcoming 2025 ARVO Annual Meeting
Published: April 18th 2025 | Updated: April 24th 2025

Companies announce presentations at upcoming 2025 ARVO Annual Meeting

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Study finds knowledge gaps in public understanding of glaucoma and cataracts
April 16th 2025

Study finds knowledge gaps in public understanding of glaucoma and cataracts

Santen receives marketing authorization application approval from NMPA of China for tafluprost/timolol maleate (Tapcom) in patients with open-angle glaucoma
April 7th 2025

Santen receives marketing authorization application approval from NMPA of China for tafluprost/timolol maleate (Tapcom) in patients with open-angle glaucoma

© 2025 MJH Life Sciences

All rights reserved.